Actionable Molecular Alterations Are Revealed in Majority of Advanced Non-Small Cell Lung Cancer Patients by Genomic Tumor Profiling at Progression after First Line Treatment

SIMPLE SUMMARY: In precision medicine, cancer patients are treated with drugs that target specific molecular alterations found in their cancer cells. As new drugs for specific targets emerge, possibilities expand. Our prospective clinical study explored the possibilities of receiving targeted treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Frank, Malene Støchkel, Bodtger, Uffe, Gehl, Julie, Ahlborn, Lise Barlebo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749927/
https://www.ncbi.nlm.nih.gov/pubmed/35008297
http://dx.doi.org/10.3390/cancers14010132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749927/
https://www.ncbi.nlm.nih.gov/pubmed/35008297
http://dx.doi.org/10.3390/cancers14010132

Ejemplares similares